Logo image of BA

BOEING CO/THE (BA) Stock Fundamental Analysis

NYSE:BA - New York Stock Exchange, Inc. - US0970231058 - Common Stock - Currency: USD

176.23  +0.36 (+0.2%)

After market: 175.789 -0.44 (-0.25%)

Fundamental Rating

1

Taking everything into account, BA scores 1 out of 10 in our fundamental rating. BA was compared to 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BA have multiple concerns. BA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BA had negative earnings in the past year.
BA had a negative operating cash flow in the past year.
In the past 5 years BA always reported negative net income.
In multiple years BA reported negative operating cash flow during the last 5 years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

BA has a Return On Assets of -7.59%. This is in the lower half of the industry: BA underperforms 71.88% of its industry peers.
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

BA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BA has more shares outstanding
BA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BA has been reduced compared to a year ago.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.07, we must say that BA is in the distress zone and has some risk of bankruptcy.
BA has a worse Altman-Z score (1.07) than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACCN/A
WACC9.87%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.32 indicates that BA should not have too much problems paying its short term obligations.
The Current ratio of BA (1.32) is worse than 70.31% of its industry peers.
BA has a Quick Ratio of 1.32. This is a bad value and indicates that BA is not financially healthy enough and could expect problems in meeting its short term obligations.
BA has a Quick ratio of 0.42. This is amonst the worse of the industry: BA underperforms 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.42
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BA have decreased strongly by -250.00% in the last year.
BA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.50%.
BA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%

3.2 Future

The Earnings Per Share is expected to grow by 20.11% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.55% on average over the next years. This is quite good.
EPS Next Y100.02%
EPS Next 2Y49.09%
EPS Next 3Y32.93%
EPS Next 5Y20.11%
Revenue Next Year24.29%
Revenue Next 2Y20.34%
Revenue Next 3Y17.39%
Revenue Next 5Y15.55%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
BA is valuated quite expensively with a Price/Forward Earnings ratio of 34846.66.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BA indicates a slightly more expensive valuation: BA is more expensive than 65.63% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, BA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 34846.66
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10K 20K 30K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BA does not grow enough to justify the current Price/Earnings ratio.
BA's earnings are expected to grow with 32.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.09%
EPS Next 3Y32.93%

More info and screens

0

5. Dividend

5.1 Amount

BA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

NYSE:BA (2/4/2025, 8:04:00 PM)

After market: 175.789 -0.44 (-0.25%)

176.23

+0.36 (+0.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)N/A N/A
Inst Owners67.55%
Inst Owner Change0.79%
Ins Owners0.07%
Ins Owner Change2.58%
Market Cap131.85B
Analysts76.67
Price Target190.58 (8.14%)
Short Float %3.08%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.02
Dividend Growth(5Y)-11.02%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.7%
Min EPS beat(2)-91.07%
Max EPS beat(2)3.66%
EPS beat(4)2
Avg EPS beat(4)-23.11%
Min EPS beat(4)-91.07%
Max EPS beat(4)37.77%
EPS beat(8)4
Avg EPS beat(8)-7.22%
EPS beat(12)4
Avg EPS beat(12)-872.64%
EPS beat(16)5
Avg EPS beat(16)-763.86%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-4.68%
Revenue beat(16)2
Avg Revenue beat(16)-5.02%
PT rev (1m)1.52%
PT rev (3m)-6.42%
EPS NQ rev (1m)-30.14%
EPS NQ rev (3m)-150.71%
EPS NY rev (1m)-97.67%
EPS NY rev (3m)-99.88%
Revenue NQ rev (1m)-2.87%
Revenue NQ rev (3m)-14.58%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-7.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34846.66
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.37
EYN/A
EPS(NY)0.01
Fwd EY0%
FCF(TTM)-19.24
FCFYN/A
OCF(TTM)-16.15
OCFYN/A
SpS88.91
BVpS-5.22
TBVpS-18.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.25%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.42
Altman-Z 1.07
F-Score2
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
EPS Next Y100.02%
EPS Next 2Y49.09%
EPS Next 3Y32.93%
EPS Next 5Y20.11%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
Revenue Next Year24.29%
Revenue Next 2Y20.34%
Revenue Next 3Y17.39%
Revenue Next 5Y15.55%
EBIT growth 1Y-1218.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.56%
EBIT Next 3Y53.12%
EBIT Next 5Y33.84%
FCF growth 1Y-424.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-302.68%
OCF growth 3YN/A
OCF growth 5YN/A